|

Gliolan Clinical Trials

1 actively recruiting trial

Also known as: 5-Aminolevulinic acid

Pipeline

Phase 1/2: 1

Top Sponsors

  • Universität Münster1

Indications

  • Glioblastoma1
  • Cancer1

Other1 trial

Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.